Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The adenosine reuptake transporter is a group of membrane transporters responsible for the cellular uptake of adenosine. These transporters, primarily belonging to the ENT (SLC29) and CNT (SLC28) families, regulate extracellular adenosine concentrations, thereby influencing purinergic signaling. They are involved in various physiological processes including neurotransmission, cardiovascular function, and immune responses, and their dysregulation can contribute to diseases such as cardiovascular disorders, neurological conditions, and cancer.
Inhibition of adenosine reuptake
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Adenosine Reuptake Transporter.